Plasma extracellular vesicles tau and β-amyloid as biomarkers of cognitive dysfunction of Parkinson's disease

Plasma Extracellular Vesicles Tau and β-Amyloid as Biomarkers of Cognitive Dysfunction of Parkinson's Disease - Chung et al. 2023

Plasma Extracellular Vesicles Tau and β-Amyloid as Biomarkers of Cognitive Dysfunction of Parkinson's Disease

© 2021 Chung, Chan, Chen, Bamodu, Chiu and Hong

FASEB Journal

Previous
Previous

Vascular risk factors and astrocytic marker for the glymphatic system activity

Next
Next

Upregulation of APAF1 and CSF1R in Peripheral Blood Mononuclear Cells of Parkinson’s Disease